BACKGROUND:Pulmonary rehabilitation (PR) is recommended for patients with respiratory disease who feel limited by breathlessness. Poor attendance wastes finite resources, increases waiting times and is probably associated with poorer clinical outcomes. We investigated what factors, identifiable from routine hospital data, predict poor attendance once enrolled in a pulmonary rehabilitation programme (PRP). METHODS: Retrospective case note study of 239 patients (60% male) of mean (S.D.) age of 66.6 (8.7) years, mean FEV(1) 39.6 (14.6)% predicted, who attended a 6 (short) or 18 (long) week, 18 session, outpatient PRP. Attendance data was analysed using linear multiple regression analysis with the log transformed odds ratio of attendance as the dependant variable. RESULTS:Overall median attendance was 16 out of 18 sessions. Being a current smoker (p<0.05), attending a long PRP (p<0.05), more previous hospital admissions (p<0.01), higher Medical Research Council (MRC) dyspnoea score (p<0.01) or enduring a long journey (p<0.001) were independent risk factors for low attendance. Lower body mass index (BMI) and distance from PR centre were of borderline importance (p<0.1) but age, gender, co-morbidity, respiratory diagnosis, FEV(1) and St. Georges Respiratory Questionnaire Score at baseline did not predict later attendance (p>0.2). CONCLUSIONS: Attendance at PRPs is independently influenced by smoking status, the degree of breathlessness, frequency of hospital admissions, length of the programme and journey time.
RCT Entities:
BACKGROUND: Pulmonary rehabilitation (PR) is recommended for patients with respiratory disease who feel limited by breathlessness. Poor attendance wastes finite resources, increases waiting times and is probably associated with poorer clinical outcomes. We investigated what factors, identifiable from routine hospital data, predict poor attendance once enrolled in a pulmonary rehabilitation programme (PRP). METHODS: Retrospective case note study of 239 patients (60% male) of mean (S.D.) age of 66.6 (8.7) years, mean FEV(1) 39.6 (14.6)% predicted, who attended a 6 (short) or 18 (long) week, 18 session, outpatient PRP. Attendance data was analysed using linear multiple regression analysis with the log transformed odds ratio of attendance as the dependant variable. RESULTS: Overall median attendance was 16 out of 18 sessions. Being a current smoker (p<0.05), attending a long PRP (p<0.05), more previous hospital admissions (p<0.01), higher Medical Research Council (MRC) dyspnoea score (p<0.01) or enduring a long journey (p<0.001) were independent risk factors for low attendance. Lower body mass index (BMI) and distance from PR centre were of borderline importance (p<0.1) but age, gender, co-morbidity, respiratory diagnosis, FEV(1) and St. Georges Respiratory Questionnaire Score at baseline did not predict later attendance (p>0.2). CONCLUSIONS: Attendance at PRPs is independently influenced by smoking status, the degree of breathlessness, frequency of hospital admissions, length of the programme and journey time.
Authors: David A Kaminsky; Kalpalatha K Guntupalli; Joan Lippmann; Stephanie M Burns; Melissa A Brock; Joan Skelly; Michael DeSarno; Heidi Pecott-Grimm; Ali Mohsin; Catherine LaRock-McMahon; Penney Warren; Martha C Whitney; Nicola A Hanania Journal: J Altern Complement Med Date: 2017-07-17 Impact factor: 2.579
Authors: Anat Galor; William Feuer; John H Kempen; R Oktay Kaçmaz; Teresa L Liesegang; Eric B Suhler; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Jennifer E Thorne Journal: Br J Ophthalmol Date: 2010-07 Impact factor: 4.638
Authors: Darcy D Marciniuk; Dina Brooks; Scott Butcher; Richard Debigare; Gail Dechman; Gordon Ford; Veronique Pepin; Darlene Reid; Andrew W Sheel; Micheal K Stickland; David C Todd; Shannon L Walker; Shawn D Aaron; Meyer Balter; Jean Bourbeau; Paul Hernandez; Francois Maltais; Denis E O'Donnell; Donna Bleakney; Brian Carlin; Roger Goldstein; Stella K Muthuri Journal: Can Respir J Date: 2010 Jul-Aug Impact factor: 2.409
Authors: Andrew M Busch; Lori A J Scott-Sheldon; Jacqueline Pierce; Elizabeth A Chattillion; Karlene Cunningham; Maria L Buckley; Jeffrey M Mazer; Cerissa L Blaney; Michael P Carey Journal: Respir Med Date: 2014-04-26 Impact factor: 3.415